Zynex(US:ZYXI) Globenewswire·2026-02-23 21:45Core Viewpoint - A class action lawsuit has been filed against Zynex, Inc. for alleged violations of federal securities laws, impacting investors who purchased Zynex securities between February 25, 2021, and December 15, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who acquired Zynex securities during the specified class period [2]. - The complaint alleges that Zynex's management made materially false and misleading statements and failed to disclose adverse facts about the company's business and operations [3]. - Specific allegations include the shipment of excess products, which inflated revenue, and a fraudulent overbilling scheme that drew scrutiny from insurers [7]. Group 2: Allegations Against Management - The complaint states that Zynex's management prioritized aggressive sales strategies over compliance with industry regulations [7]. - It is alleged that the company's order growth was a result of illegal overbilling practices, leading to potential penalties and removal from insurer networks [7]. - The lawsuit claims that positive statements made by the defendants regarding the company's prospects were materially misleading [7]. Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis, meaning they will only collect fees if the case is successful [4]. - The firm has a history of recovering significant amounts for investors in securities fraud cases [5]. - Investors are encouraged to join the lawsuit and can contact the firm for more information [3][8].